CAS 1007476-63-2

MJ33 lithium salt

CAS: 1007476-63-2

MJ33 lithium salt

Pureza: ≥98%

Peso molecular: 498.48g/mol

Ref: 54-BUP22030

MJ33 lithium salt

CAS: 1007476-63-2

MJ33 lithium salt is an inhibitor of NADPH oxidase type 2-mediated ROS generation, inhibits PLA2 activity, and can be used to study acute lung injury.

Fórmula: C₂₂H₄₃F₃LiO₆P

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 498.48

Ref: TM-T38404

Mj 33 lithium

CAS: 1007476-63-2

Mj 33 lithium is a potent and selective antibody that inhibits the activation of ion channels. It binds to the ligand-binding domain of receptors, preventing agonist binding and subsequent signal transduction. Mj 33 lithium has been shown to be an inhibitor of receptor tyrosine kinases, including type I insulin-like growth factor receptor (IGF1R), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor 2 (VEGFR2). It also has been shown to inhibit the activation of voltage-gated sodium channels in rat dorsal root ganglia neurons.

Fórmula: C₂₂H₄₄F₃LiO₆P

Pureza: Min. 95%

Peso molecular: 499.5 g/mol

Ref: 3D-HQB47663